Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ferrante

Showing results (161-170 of 246) with videos related to

Pageof 25
Sort By:
Journal of Neurochemistry|August 1, 1995
3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic miceM F Beal, R J Ferrante, R Henshaw, et al.
The Journal of Comparative Neurology|August 30, 2005
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic miceEdward C Stack, James K Kubilus, Karen Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineP Klivenyi, O A Andreassen, R J Ferrante, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 12, 2008
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis miceSteven J Del Signore, Daniel J Amante, Jinho Kim, et al.
Annals of Neurology|October 23, 1997
Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutationR J Ferrante, L A Shinobu, J B Schulz, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2000
Neuroprotective effects of creatine in a transgenic mouse model of Huntington's diseaseR J Ferrante, O A Andreassen, B G Jenkins, et al.
Journal of Neurochemistry|January 1, 1993
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acidE Brouillet, B G Jenkins, B T Hyman, et al.
Human Molecular Genetics|June 1, 1994
A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosisD R Rosen, A C Bowling, D Patterson, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Pageof 25

Showing results (161-170 of 246) with videos related to

Sort By:
Pageof 25
Journal of Neurochemistry|August 1, 1995
3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide dismutase transgenic miceM F Beal, R J Ferrante, R Henshaw, et al.
The Journal of Comparative Neurology|August 30, 2005
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic miceEdward C Stack, James K Kubilus, Karen Smith, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 11, 2000
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineP Klivenyi, O A Andreassen, R J Ferrante, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 12, 2008
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis miceSteven J Del Signore, Daniel J Amante, Jinho Kim, et al.
Annals of Neurology|October 23, 1997
Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutationR J Ferrante, L A Shinobu, J B Schulz, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 14, 2000
Neuroprotective effects of creatine in a transgenic mouse model of Huntington's diseaseR J Ferrante, O A Andreassen, B G Jenkins, et al.
Journal of Neurochemistry|January 1, 1993
Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acidE Brouillet, B G Jenkins, B T Hyman, et al.
Human Molecular Genetics|June 1, 1994
A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosisD R Rosen, A C Bowling, D Patterson, et al.
ACS Medicinal Chemistry Letters|March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Pageof 25